Atypical ruminant pestiviruses are closely related to the two bovine viral diarrhoea virus (BVDV) species, BVDV-1 and BVDV-2. While there is evidence of cross-protective immune responses between BVDV-1 and BVDV-2, despite antigenic differences, there is little information on the antigenic cross-reactivity with atypical ruminant pestiviruses. The aim of this study was therefore to assess the specificity of antibody and T cell responses induced by experimental infection of calves with BVDV-1 strain Ho916, Th/04_KhonKaen (TKK), an Asiatic atypical ruminant pestivirus, or co-infection with both viruses. Homologous virus neutralization was observed in sera from both single virus infected and co-infected groups, while cross-neutralization was only observed in the TKK infected group. T cell IFN-c responses to both viruses were observed in the TKK infected animals, whereas Ho916 infected calves responded better to homologous virus. Specifically, IFN-c responses to viral non-structural protein, NS3, were observed in all infected groups while responses to viral glycoprotein, E2, were virus-specific. Broader antigen-specific cytokine responses were observed with similar trends between inoculation groups and virus species. The limited T cell and antibody immune reactivity of Ho916 inoculated animals to TKK suggests that animals vaccinated with current BVDV-1-based vaccines may not be protected against atypical ruminant pestiviruses.
Introduction
The Pestivirus genus within the Flaviviridae family of single stranded positive-sense RNA viruses comprises four recognized species: BVDV-1, BVDV-2, classical swine fever virus (CSFV) and border disease virus (BDV) [1] . Additionally, eight groups of unclassified pestiviruses have been discovered: giraffe, pronghorn antelope, Bungowannah, atypical ruminant, sheep, bat, rat and atypical porcine pesitiviruses [2, 3] . Atypical ruminant pestiviruses, informally referred to as BVDV-3 or HoBi-like viruses, which form a monophyletic clade with a sister relationship to BVDV-1 and -2, have been detected in contaminated foetal bovine serum (FBS) and in natural infections in cattle and buffalo [4, 5] . While the evidence suggests atypical bovine pestiviruses are present in cattle in South America, Southeast Asia and Europe, there is a need for broader surveillance to assess the extent of their geographic distribution and the possible impact on current and future BVDV control programs.
Genetic and antigenic diversity of bovine pestiviruses may pose a significant challenge to BVDV diagnosis and vaccination. Diagnosis by detection of viral material or through quantification of virus-specific immune responses may be hampered by the variability within these targets making it difficult to recognise divergent or atypical viruses [6] . Furthermore, limited virus cross-neutralization and failure in detection of seroconversion to https://doi.org/10.1016/j.vaccine.2018.06.019 0264-410X/Crown Copyright Ó 2018 Published by Elsevier Ltd. All rights reserved. atypical pestiviruses using commercial ELISA (based on BVDV-1) is evidence of significant antigenic diversity between atypical pestiviruses and BVDV-1 and -2 [7] . This also raises questions regarding the actual distribution of atypical pestiviruses and potential efficacy of existing BVDV vaccines against these divergent viruses. Whilst clinical cross-protection against BVDV-2 challenge has been reported using BVDV-1 vaccines, vaccination failure has been attributed to virus diversity and inadequate protection from foetal infection, postnatal infection and virus shedding [8, 9] . In future, vaccines may have to be designed with protection against BVDV-1 and -2 species and sub-genotypes as well as atypical bovine pestiviruses in mind [9] . This may be achieved by inclusion of different virus genotypes/species, identification of targets of cross-protective immune responses, or by the use of speciesspecific vaccines.
This study, conducted as part of a study comparing the infection kinetics and pathogenesis of calves experimentally infected with a BVDV-1a strain (Ho916), an Asiatic atypical ruminant pestivirus (Th/04_KhonKaen) or co-infection with both viruses, aimed to assess whether antibody and T cell responses induced by one virus were capable of responding to the heterologous virus and to determine if the immunodominant antigens, E2 glycoprotein and nonstructural protein NS3, were targets of cross-reactive or distinct species-specific responses.
Materials and methods

Viruses and animals
The study used the non-cytopathic BVDV-1a strain Ho916, isolated from a clinically severe outbreak of BVD in the United Kingdom [10, 11] , and the non-cytopathic atypical bovine pestivirus Th/04_KhonKaen (TKK), which was recovered from a dairy calf in Thailand [12, 13] . Both viruses were propagated in low passage foetal bovine turbinate (fBT) cells and virus titres determined as the median (50%) tissue culture infectious dose (TCID 50 ) using the Spearman-Kärber method following immunoperoxidase staining [14] . Twenty 3-5 month old, BVDV-naïve Holstein calves were randomly assigned into 4 groups of 5 animals. The calves were confirmed to be BVDV antibody and antigen negative to rule out pre-exposure and persistent infection. Calves were inoculated with 10 5 TCID 50 of Ho916, TKK or a mixture of both viruses (Ho916/ TKK). Each animal was inoculated with the appropriate virus or viruses diluted in 10 mL EMEM (Invitrogen, Thermo Fisher Scientific, Paisley, UK) by intranasal (5 mL) and intramuscular (5 mL) routes simultaneously in 1 mL of EMEM (Invitrogen, Thermo Fisher Scientific, Paisley, UK). Control animals (Controls) were similarly inoculated with 10 mL of EMEM only. Assessment of clinical scores including rectal temperature and sampling of blood and nasal secretions was conducted up to 45 days post-infection (dpi). The study was approved by the Ethics Committee for Animal Experiments by the Ministry of Science and Higher Education in Poland (No. 79/2010) and details of the procedures and outcome of the experimental infection are previously described [15] . In brief, milder clinical signs were observed in the TKK group and coinfection resulted in prolonged pyrexia in comparison to the single infection groups. Similar courses of viraemia were measured in all three infected groups. Simultaneous detection of both viruses in blood and nasal swabs was observed in the co-infected group. All inoculated groups seroconverted two weeks after inoculation as assessed by serum neutralisation of homologous virus. In addition to Ho916 and TKK viruses, BVDV-1a C24V (C24V) [16] , BVDV-2 502643-02-UK (BVDV-2) [17] and border disease virus 1 S137/4 (BDV-1) [18] reference strains were used to assess serological cross reactivity.
Detection of antibody responses
Competitive ELISAs were used for the detection of antibodies against BVDV-1 NS3 (SVANOVIR Ò BVDV p80, Svanova Biotech AB, Uppsala, Sweden) and E2 (VDPro Ò BVDV, Jeno Biotech, Chuncheon, Republic of Korea) according to the manufacturer's instructions. Virus neutralizing antibody titres (VNT) in pooled serum samples for each inoculation group at 42 dpi were determined against Ho916, TKK, C24V, BVDV-2 and BDV-1 as described previously [19] . VNT were calculated as reciprocal of the highest serum dilution that inhibited virus growth by 50% using the SpearmanKärber method and expressed on a log 2 scale [14] . The extent of cross-reactivity was calculated from log transformed VNTs as a percentage of heterologous virus neutralisation compared to homologous neutralisation [20] .
Synthetic pestiviral peptides
Predicted amino acid sequences of Ho916 E2 and NS3 (GenBank MH379638) were aligned against the reference strain C24V (GenBank AF091605.1) and Th/04_KhonKaen (GenBank FJ040215.1) using the ClustalW algorithm on MegAlign (DNAStar Lasergene 9 Core Suite, Madison, WI, USA). Based on the divergence of the E2 and conservation of NS3 between the three viruses, overlapping pentadecamer peptides offset by four residues (JPT Peptide Technologies, Berlin, Germany) were synthesised covering the complete E2 protein from C24V, Ho916 and TKK ( Fig. 1) , and the NS3 protein of C24V only (Fig. 2) . Lyophilised peptides were dissolved in 0.1 M HEPES pH 7.4-buffered 40% acetonitrile and pooled to represent the respective E2 and NS3 proteins. Peptide pools were diluted in RPMI-1640 medium supplemented with 2 mM L-glutamine, 20 mM HEPES, 100 U/mL penicillin, 100 lg/mL streptomycin, 50 mM 2-mercaptoethanol (all Invitrogen) and 10% FBS (Autogen Bioclear, Calne, UK) (cRPMI).
Ex vivo stimulation of peripheral blood mononuclear cells and assessment of cytokine responses
Peripheral blood mononuclear cells (PBMC) from calves were isolated weekly from heparinised blood by density centrifugation using Histopaque-1077 (Sigma, Poole, UK), suspended in cRPMI, and added 5 Â 10 5 cells/well to 96 well round-bottom plates. Cells were stimulated in duplicate wells with 100 ll of peptide pools representing the E2 and NS3 proteins at 1 lg/mL or viruses at a multiplicity of infection of 1. Medium or mock-infected fBT supernatant and pokeweed mitogen (Sigma) were used as negative and positive controls respectively. The cells were incubated at 37°C for 48 h after which cell-free supernatants were harvested after centrifugation and stored at À80°C until analysed. The release of IFN-c in culture supernatants was measured using a bovine IFNc ELISA as previously described [21] . IFN-c, IL-4, IL-10 and MIP1b were simultaneously quantified using a custom-designed multi-array electrochemiluminescence detection assay (Meso Scale Discovery, Gaithersburg, USA) as described [22] .
Data analysis and statistics
Graphical and statistical analysis was performed using GraphPad Prism 7.01 (GraphPad Software, La Jolla, USA). Data was represented as means with standard error of means (SEM) shown to indicate the uncertainty around the estimate of the group means. Two-way ANOVA followed by a Dunnett's or Tukey's multiple comparison tests were used for the analysis of virus strain specific effects on antibody and cytokine responses in the different infection groups. P values are indicated on figures.
Results
Assessment of virus-specific antibody responses
The Ho916 and Ho916/TKK infected groups mounted E2 specific antibody response at 14 dpi (Fig. 3A) as determined by a competitive BVDV ELISA. While the E2 specific antibody levels in the TKK group increased from 14 dpi they were not above the cut-off until 21 dpi. The E2 specific antibody levels of the Ho916 and Ho916/ TKK groups were significantly higher than in the TKK group from 14 dpi. The Ho916 and Ho916/TKK groups showed NS3 antibody responses (Fig. 3B ) from 21 dpi compared to the control group, whilst the TKK group responses were significantly higher compared to the controls from 28 dpi but did not exceed the diagnostic cut-off for assay positivity until 35 dpi. Ho916 group responses were significantly greater than the TKK group at 21 and 28 dpi, whereas, Ho916/TKK antibody levels were greater than TKK between 14 and 35 dpi. There were no significant differences in NS3 responses between Ho916 and Ho916/TKK groups. Homologous neutralization of both Ho916 and TKK viruses was observed from 14 dpi in the single and co-infected groups. However, neutralization of Ho916 virus by sera from TKK inoculated cattle only occurred at low titres at 42 dpi while low titres of TKK-neutralizing antibodies was observed in Ho916 inoculated animals from 21 dpi. We further assessed the cross-neutralising properties of these sera by comparing neutralisation of the inoculated viruses, and reference strains BVDV-1a C24V, BVDV-2 50263-02-UK and BDV-1 S137/4 (Fig. 4A) . Ho916 virus neutralization titres in both Ho916 and Ho916/TKK group sera were higher than the TKK group sera and a similar pattern was observed against C24V and BDV-1 but with lower titres. In contrast, TKK virus was neutralized by TKK and Ho916/TKK inoculated group sera but not by the Ho916 inoculated animals' sera. Neutralization of BVDV-2 was observed at low titres in all inoculated groups with the lowest titres in sera from Ho916 inoculated animals. Ho916 and Ho916/TKK group sera better neutralized BDV compared to sera from the TKK inoculated animals. Assessment of cross-neutralisation, calculated as the percentage of heterologous versus homologous neutralization, showed that despite exhibiting weaker homologous neutralization, TKK group sera showed comparatively good neutralization of Ho916, C24V and BVDV-2 (Fig. 4B) . Ho916 group sera showed crossneutralization of C24V albeit with lower titres compared to homologous neutralization. While cross-neutralization of all other viruses by sera from the Ho916 inoculated animals was considerably less than homologous virus neutralization. Cross-neutralization of BDV-1 by sera from all inoculation groups was poor.
Assessment of virus-specific T cell responses
In comparison to uninfected controls, significant ex vivo PBMC IFN-c responses were observed against Ho916 and TKK viruses from 35 dpi (Fig. 5) . PBMC from the Ho916 inoculated group Fig. 1 . Alignment of translated E2 protein sequences from BVDV-1 Ho916, atypical pestivirus TKK and BVDV-1 reference strain C24V. Sequences were aligned using Clustalw and distances calculated from construction of phylogenetic tree (PAM250) on MegAlign (DNA Star Inc.). Sequence distances calculated as divergence based on comparison of sequence pairs in relation to a phylogeny reconstruction and as percent identity, which compares both sequences directly without accounting for phylogenetic relationships, are presented in the tables. stimulated with Ho916 virus showed statistically significant IFN-c responses on 42 dpi, whilst responses in the TKK group significant on 35 and 42 dpi. Responses to Ho916 virus in the Ho916/TKK group were less than in the other two groups and were not statistically significant. Responses to the TKK virus on the other hand, were significant in both the TKK and Ho916/TKK groups at 35 and 42 dpi. Responses to the TKK virus by PBMC from the Ho916 group were not statistically significant. IFN-c responses to E2 peptide pools at 42 dpi followed similar trends to the responses to virus (Fig. 6A) . IFN-c responses to the E2 peptide pool representing Ho916 virus (E2-Ho916) were observed in the Ho916 and Ho916/ TKK groups but not in the TKK group. Responses to E2-TKK peptide pool were seen in the TKK and Ho916/TKK groups, albeit only statistically significant in the TKK group. IFN-c responses to the NS3 peptide pool were observed in all infected groups and were statistically significant in the Ho916 and TKK infected groups. Broader cytokine responses including IL-10, IL-4 and MIP-1b were observed following virus and peptide stimulation (Fig. 6B-D) . TKK infected animals were observed to elicit a broad cytokine response following stimulation with homologous virus, as well as heterologous virus. Significant quantities of IL-4, IL-10, and MIP-1b were secreted by PBMC from TKK infected animals following TKK and Ho916 stimulation. With the exception of MIP-1b, the other cytokines were not secreted to significant levels in the Ho916 infected animals following stimulation with the TKK virus. While IL-4 production was observed at lower levels in the co-infected animals in response to both viruses, IL-10, and MIP-1b were secreted in significant levels in this group following TKK stimulation. Significant IL-4 responses to the E2-Ho916 were observed in the Ho916 virus and co-infected groups and to the NS3 C24V peptide pool in the coinfected group but not against E2-TKK in any of the infected groups. IL-10 responses against NS3 and E2-TKK peptide pools Fig. 2 . Alignment of translated NS3 protein sequences from BVDV-1 Ho916, atypical pestivirus TKK and BVDV-1 reference strain C24V. Sequences were aligned using Clustalw and distances calculated from construction of phylogenetic tree (PAM250) on MegAlign (DNA Star Inc.). Sequence distances calculated as divergence based on comparison of sequence pairs in relation to a phylogeny reconstruction and as percent identity, which compares both sequences directly without accounting for phylogenetic relationships, are presented in the tables.
were observed in the Ho916 infected group, and against E2-TKK peptide pool in the TKK infected group while the co-infected group had significant responses to both E2 peptide pools and NS3. MIP-1b responses were significant in all infected groups to E2-Ho916 and NS3 and to E2-TKK in the TKK and co-infected groups.
Discussion
Recent disease outbreaks within the EU, in Asia and South America caused by atypical ruminant pestiviruses have highlighted a group of viruses that have thus far received little attention. Comparative analyses of antigenic relationships between atypical ruminant pestiviruses and BVDV-1 and BVDV-2 point towards the need for improved diagnostics and reformulation of current vaccines for the detection and control of these new viruses [7] . This study aimed to increase the understanding of antigenic diversity on both T cell and humoral responses to BVDV-1 and atypical pestiviruses.
In this study, both BVDV-1 E2 and NS3 specific antibody responses were detected in all infected groups 14-21 dpi postinfection albeit to a lesser extent in the TKK group. This raises questions about the sensitive detection of antibodies against atypical ruminant pestiviruses, such as TKK, by diagnostic ELISAs designed to detect antibodies against BVDV- 1 [6] . This is supported by the limited detection of antibodies to a European atypical bovine pestivirus, Italy-1/10-1, using a commercial BVDV-1-based ELISA, despite high neutralization titres [23] . In the present study, NS3 antibodies were better detected than antibodies against the less conserved E2 protein. It has recently been proposed that diagnostics for BVDV and atypical pestiviruses should be based on NS2/3 or E rns as they potentially possess more cross-reactive epitopes, while assays targeting E2 may allow discrimination of pestivirus species [7] . Homologous virus neutralization was observed in all infected groups, yet cross-neutralization was only observed against the Ho916 virus in the TKK infected group, whose sera was able to neutralize the Ho916 virus almost to the same extent as the homologous virus. The relatively low homologous neutralizing antibody titres against TKK however, are suggestive of an inferior antibody response compared to the more robust titres in the Ho916 infected and co-infected groups. While similar patterns of cross-neutralisation were observed between BVDV-1 and atypical pestivirus sera against BDV-1, atypical pestivirus serum appeared to neutralize BVDV-2 better than BVDV-1 serum. Limited cross neutralization activity, alluding to significant antigenic differences between BVDV-1 and -2 and atypical ruminant pestiviruses have been previously reported [13, 24, 25] . A degree of cross-reactivity of T cell responses in TKK infected animals after re-stimulation with Ho916 virus was observed. However, IFN-c responses to TKK virus were low in the Ho916 infected group. IFN-c responses to E2 peptide pools were virus species specific whilst responses to the more conserved NS3 target appear to be maintained, to different extents, in all the infected groups. Broader cytokine responses to E2 and NS3 peptide pools followed similar trends to IFN-c. Responses to E2-Ho916 were not observed in the TKK infected group, with the exception of MIP-1b. Similarly, responses to E2-TKK were, by large, absent in the Ho916 group, while as observed with IFN-c, a number of cytokine responses were observed to the NS3 peptide pool in all the infected groups. These observations, taken together, point towards E2 responses being virus specific, with responses to the NS3 antigen being better conserved between the viruses.
The limited T cell and antibody immune reactivity of Ho916 inoculated animals to Th/04_KhonKaen suggests that animals vaccinated with BVDV-1-based vaccines may not be protected against atypical ruminant pestiviruses. There is discussion on whether atypical ruminant pestiviruses should be recognized as a third BVDV species and if so, what implications this might have, from a regulatory point of view, for currently licensed BVD diagnostics and vaccines as well as for the BVDV control programmes and eradication status of countries and regions [26] . There is increasing evidence of the clinical and epidemiological relevance of these emerging viruses with clinical disease following experimental infection in cattle and sheep and reports of natural infections in Southeast Asia, South America and Europe [5] . Antigenic variation between BVDV-1 and -2 species has already led to the inclusion of BVDV-2 strains in some vaccines [27] , and this needs to be considered in the case of atypical ruminant pestiviruses. Vaccine efficacy studies should also include challenge with heterotypic BVDV isolates as well as novel antigenically distinct variants [28] . 
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